These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8630089)

  • 1. Inhibition of squalene synthase of rat liver by novel 3' substituted quinuclidines.
    McTaggart F; Brown GR; Davidson RG; Freeman S; Holdgate GA; Mallion KB; Mirrlees DJ; Smith GJ; Ward WH
    Biochem Pharmacol; 1996 Jun; 51(11):1477-87. PubMed ID: 8630089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of squalene synthase in vitro by 3-(biphenyl-4-yl)-quinuclidine.
    Ward WH; Holdgate GA; Freeman S; McTaggart F; Girdwood PA; Davidson RG; Mallion KB; Brown GR; Eakin MA
    Biochem Pharmacol; 1996 Jun; 51(11):1489-501. PubMed ID: 8630090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
    Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
    J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squalene synthase as a chemotherapeutic target in Trypanosoma cruzi and Leishmania mexicana.
    Urbina JA; Concepcion JL; Rangel S; Visbal G; Lira R
    Mol Biochem Parasitol; 2002; 125(1-2):35-45. PubMed ID: 12467972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative and ultrastructural effects of BPQ-OH, a specific inhibitor of squalene synthase, on Leishmania amazonensis.
    Rodrigues JC; Urbina JA; de Souza W
    Exp Parasitol; 2005 Dec; 111(4):230-8. PubMed ID: 16198340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
    Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
    Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological control of biosynthesis pathway of mevalonate: effect on the proliferation of arterial smooth muscle cells].
    Corsini A; Arnaboldi L; Quarato P; Ferri N; Granata A; Fumagalli R; Paoletti R
    C R Seances Soc Biol Fil; 1997; 191(2):169-94. PubMed ID: 9255346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
    Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase.
    Wentzinger LF; Bach TJ; Hartmann MA
    Plant Physiol; 2002 Sep; 130(1):334-46. PubMed ID: 12226513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
    Petras SF; Lindsey S; Harwood HJ
    J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors.
    Harwood HJ; Barbacci-Tobin EG; Petras SF; Lindsey S; Pellarin LD
    Biochem Pharmacol; 1997 Mar; 53(6):839-64. PubMed ID: 9113105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses of 3-ethylidenequinuclidine derivatives as squalene synthase inhibitors. Part 2: enzyme inhibition and effects on plasma lipid levels.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto Si; Yanagisawa I
    Bioorg Med Chem; 2003 Aug; 11(17):3735-45. PubMed ID: 12901918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
    Amin D; Cornell SA; Perrone MH; Bilder GE
    Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of squalene synthase inhibitors on the growth and ultrastructure of Trypanosoma cruzi.
    Braga MV; Urbina JA; de Souza W
    Int J Antimicrob Agents; 2004 Jul; 24(1):72-8. PubMed ID: 15225865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi.
    Urbina JA; Concepcion JL; Caldera A; Payares G; Sanoja C; Otomo T; Hiyoshi H
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2379-87. PubMed ID: 15215084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of 3-(biphenyl-4-yl)-3-hydoxyquinuclidine (BPQ-OH) and metronidazole on Trichomonas vaginalis: a comparative study.
    Rocha DA; de Andrade Rosa I; Urbina JA; de Souza W; Benchimol M
    Parasitol Res; 2014 Jun; 113(6):2185-97. PubMed ID: 24752367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
    Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
    J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
    Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.